INTRODUCTION:

Background on Conventional Drug Delivery Systems

The cornerstone of pharmacological treatment for a long time has been conventional drug delivery systems, which provide a way to distribute drugs under strict control to produce therapeutic effects. Oral pills, capsules, injections, transdermal patches, and other formulations intended to deliver medications to the body are commonly included in these systems.¹

Even though oral formulations are popular and convenient, they frequently have issues that might impair the bioavailability and effectiveness of drugs, such as varying absorption rates, enzymatic degradation in gastrointestinal tract (GIT) and first pass metabolism in liver.²

Transdermal patches offer a different approach to drug administration by putting drugs under the skin for systemic absorption. However, only medications that can successfully cross the skin barrier can be delivered transdermally, and variables like skin permeability and patch design can affect how quickly a drug absorbs.³Conventional drug delivery systems are widely used; nevertheless they have inherent limitations that may affect treatment outcomes. These restrictions consist of low drug solubility, restricted tissue penetration, non-specific targeting, and an inability to regulate the kinetics of drug release.⁴Smart polymer matrices are a cutting-edge method of medication administration that provide customized answers to get around the drawbacks of traditional systems.⁸

Need for Drug Release Systems on Demand:

On-demand system of drug release has become increasingly crucial in modern pharmaceutical research and clinical practice due to their ability to overcome the disadvantages of traditional drug delivery techniques. Additionally, they increase patient compliance by providing more convenient dose schedules, which eventually improves therapeutic results.⁵

Overview of Smart Polymer Matrices:

Smart polymers are characterized by their capability to respond to external stimuli, like as light, temperature or pH and can be engineered to possess particular properties like self-healing, shape memory and substances controlled release.⁶ Advantages and limitations of smart polymer matrices are summarized in figure 1.

Figure 1: Advantages and Disadvantages of Smart Polymer Matrices

The properties of smart polymer matrices are evaluated through various processes like as Fourier Transform Infrared Analysis (FTIR), Nuclear Magnetic Resonance (NMR) spectroscopy, Thermal Analysis (TGA and DSC), Atomic Force Microscopy (AFM) and Scanning Electron Microscopy (SEM). These properties include chemical structure, crosslink density, swelling degrees, mechanical properties, release features, hydrophobicity, biodegradability, surface morphology, biocompatibility and toxicity.⁷

TYPES OF SMART POLYMER MATRICES:

Smart polymer matrices can be classified in to several varieties based on their properties and functions. This article summarizes about stimuli-responsive polymers with their different types in detail.

Stimuli-Responsive Polymers:

It is utilized in a various applications due to their notable property changes. These include biosensing, artificial muscles, tissue production and repair, on-demand medication delivery, and smart coatings. The polymers are intended to respond to particular stimuli, like as temperature or pH, which enables targeted and controlled delivery of substances.⁸The utilization of stimuli-responsive polymers in sensing technologies and actuation has gained significant interest due to their versatility in responding to various stimuli. This has led to the development of devices that can check human health and identify environmental analytes, as well as artificial muscles and soft robotics.⁹

pH-Responsive Polymer:

pH-responsive polymer is a class of smart polymers that undergo modification in their structures and properties in response to changes in pH. The changes in pH can induce significant transformations in the polymer's structure, such as reversible phase transitions between soluble and insoluble states, conformational changes between alpha-helix and random coil, and changes in solubility^10-11pH-responsive polymers are synthesized utilizing various techniques, such as atom transfer radical and emulsion polymerization. They offer significant advantages over traditional polymers, including controlled release profiles, minimal off-target effects, and targeted delivery of substances.^12,13

Temperature-Responsive Polymer:

Thermoresponsive polymers, another name for temperature-responsive polymers, are a class of polymers that show abrupt, sharp changes in their physical characteristics in response to temperature. Lower Critical Solution Temperature (LCST) is typically identified in aqueous solutions, where polymer chain collapses from an expanded coil conformation to compact globular structure at a specific temperature.¹⁴The characterization of temperature-responsive polymer solutions involves methods such as turbidimetry, which measures the phase separation by monitoring the transmittance of light through the solution.^15,16

Mechanisms of Stimuli-Induced Drug Release:

Stimuli-induced drug release mechanisms involve various chemical and physical changes in response to internal or external stimuli. These changes can lead to drugs controlled release from delivery systems, enhancing their therapeutic efficacy and reducing side effects. The mechanisms of drug release include are discussed below and summarized in figure 2.¹⁷

Figure 2: Mechanisms of Stimuli-Induced Release of Drug

These steps collectively represent the process of stimuli-induced drug release from polymer matrices, highlighting the complex interplay between external stimuli, polymer properties, and drug release kinetics in achieving controlled and targeted drug delivery.

Examples of Smart Polymer Matrices in Drug Delivery:

Several examples of smart polymer matrices have been prepared and employed in drug delivery systems which is discussed below.

Poly(N-isopropylacrylamide) (PNIPAAm):

The well-known thermoresponsive polymer PNIPAAm experiences a reversible phase transition in the vicinity of its approximately 32°C LCST. PNIPAAm is soluble in water and hydrophilic below the LCST, but hydrophobic and precipitating above the LCST. PNIPAAm-based hydrogels have been utilized for controlled delivery of drug, where release of drug is triggered by changes in temperature.

Poly(acrylic acid) (PAA):

PAA is a polymer with ionizable carboxylic acid groups that responds to pH. Because of variations in ionization, it expands in basic environments and contracts in acidic environments. For oral drug delivery, PAA-based hydrogels have been used; in this case, controlled drug release is triggered by pH gradient along GIT.

Poly(ethylene glycol) (PEG):

PEG is a biocompatible polymer which is frequently utilized in applications related to medication delivery. PEGylation is the conjugation of PEG chains with drugs or nanoparticles to enhance the solubility, stability, and half-life of the drug in circulation. PEG-based liposomes, nanoparticles and micelles have been prepared for sustained release and targeted drug delivery.

Poly(lactic-co-glycolic acid) (PLGA):

The creation of controlled-release medication delivery systems has made extensive use of PLGA, a biocompatible and biodegradable polymer. A variety of medications can be encapsulated in PLGA nanoparticles and microspheres and released gradually over time.^18-22

RECENT ADVANCES IN SMART POLYMER MATRICES:

pH-Responsive Polymers: Design Strategies and Applications:

The development of pH-responsive polymers, which alter their characteristics in response to pH variations, enables the precise and regulated delivery of drugs. The synthesis of pH-responsive polymers typically includes use of monomers with acidic or basic functional groups like carboxylic acid, sulfonyl, or amino groups. Modifying the molecular weight, crosslinking density and monomer composition allows for the customization of the characteristics of pH-responsive polymers. This allows for polymers creation with specific pH-responsive properties, like volume, solubility and chain conformation.^23-25

In drug delivery, pH-responsive polymers are used to release drugs in response to changes in pH, like as those that occur in body during disease states. In biomedical devices, pH-responsive polymers are utilized to develop implantable devices which can respond to changes in pH, such as those that occur in the body during disease states. pH-responsive polymers offer significant advantages over traditional polymers, including controlled release profiles, minimal off-target effects, and targeted delivery of substances.^26-28

Temperature-Responsive Polymers: Synthesis Methods and Drug Release Kinetics:

Temperature-responsive polymers are synthesized using various methods that involve the incorporation of thermoresponsive monomers, such as N-isopropylacrylamide (NIPAAm), into polymer chains. When exposed to temperature fluctuations, these polymers display a reversible phase transition from a hydrated coil to hydrophobic globule. Synthesis methods for temperature-responsive polymers include:

Radical Polymerization:

This process starts the polymerization reaction by using free radicals. It is commonly used for poly(N-isopropylacrylamide) (PNIPAAm) synthesis and other thermoresponsive polymers.²⁹

Atom Transfer Radical Polymerization (ATRP):

This method includes the utilization of a transition metal catalyst to introduce polymerization reaction. Its capacity to create polymers with regulated molecular weights and restricted molecular weight distributions is well known.³⁰

Emulsion Polymerization:

This method involves use of an emulsion of monomers in water to initiate the polymerization reaction. It is commonly used for synthesis of thermoresponsive polymers with particular properties.³¹

Smart polymer matrices offer unique properties which can be harnessed for various drug delivery applications, allowing for precise control over release of drug in response to specific stimuli. The different type of smart polymer matrices along with their properties are summarized in table 1.

APPLICATIONS IN ANTI-ANGINAL DRUG DELIVERY:

Rationale for Utilizing Smart Polymer Matrices in Anti-Anginal Therapy:

The utilization of smart polymer matrices in anti-anginal therapy offers several compelling rationales, each contributing to the improvement of treatment efficacy and patient outcomes:

Precise Drug Delivery:

Anti-anginal drugs, such as nitrates and β-blockers, often need precise dosing to accomplish optimal therapeutic effects while decreasing side effects. Smart polymer matrices enable controlled and targeted drug delivery, allowing for the release of medications directly to the affected cardiac tissues or vasculature.³⁸

On-Demand Drug Release:

Periodic episodes of chest pain or discomfort brought on by a reduction in blood supply to the heart muscle characterize angina pectoris. Smart polymer matrices can be engineered to respond to physiological cues associated with anginal episodes, such as changes in pH, temperature, or mechanical stress.³⁹

Extended Drug Release:

Chronic management of angina often requires long-term administration of anti-anginal medications to prevent recurrent symptoms and cardiovascular events. Drugs are released from smart polymer matrices gradually over a prolonged period of time, preserving therapeutic drug levels in the bloodstream and minimizing the need for frequent dosing.⁴⁰

Minimization of Side Effects:

Many anti-anginal drugs have systemic side effects, such as hypotension, bradycardia, and headache, which can limit their tolerability and compliance. This targeted drug delivery approach enhances the safety profile of anti-anginal therapy and improves patient tolerance.⁴¹

Personalized Medicine:

Angina is a heterogeneous condition with diverse underlying pathophysiological mechanisms and clinical presentations. Personalized medicine can be facilitated by smart polymer matrices, which can customize drug delivery systems based on unique patient attributes, like disease severity, comorbidities, and treatment response.⁴²

In vitro and In vivo Studies Evaluating Efficacy:

In vitro and in vivo studies evaluating efficacy of smart polymer matrices in drug delivery systems provide critical insights into their performance, safety, and therapeutic potential.

In vitro Studies:

In vitro evaluations typically involve experiments conducted in controlled laboratory settings using cell culture models or tissue-mimicking systems. Key aspects of in vitro studies include:

Drug Release Kinetics:

In vitro studies assess release profile of drugs from smart polymer matrices under different environmental stimuli, like as changes in temperature, pH or enzyme activity. These experiments involve incubating the polymer matrix with a model drug in buffer solutions or cell culture media and quantifying the release of the drug over time using analytical techniques.⁴³

Mechanistic Studies:

In vitro studies also aim to elucidate the underlying mechanisms governing drug release from smart polymer matrices. Techniques like Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and nuclear magnetic resonance (NMR) spectroscopy are employed to analyze changes in polymer structure and morphology in response to stimuli.⁴⁴

Biocompatibility Assessments:

Biocompatibility evaluations are essential to ensure safety of smart polymer-based drug delivery systems for clinical applications. In vitro cytotoxicity assays using cell lines or primary cell cultures assess the impact of polymer matrices and released drugs on cell viability, proliferation, and morphology.⁴⁵

In vivo Studies:

In vivo studies provide valuable information on systemic drug distribution, tissue targeting, pharmacokinetics, and pharmacodynamics. Key aspects of in vivo studies include:

Pharmacokinetic Analysis:

In vivo studies assess the systemic exposure and distribution of drugs released from smart polymer matrices following administration. Pharmacokinetic parameters, including area under the curve (AUC), half-life (t1/2) and maximum plasma concentration (Cmax), are calculated to characterize drug absorption, distribution, metabolism, and elimination.

Therapeutic Efficacy:

In vivo efficacy studies evaluate the ability of smart polymer-based drug delivery systems to achieve therapeutic outcomes in disease models. Animal models of relevant pathologies, such as cardiovascular disease or cancer, are utilized to assess efficacy of drug delivery system in alleviating symptoms, reducing disease progression, or improving survival outcomes.⁴⁶

Biocompatibility and Tissue Response:

In vivo studies also investigate the biocompatibility and tissue response to smart polymer-based drug delivery systems. Histological analysis of tissue samples collected from treated animals allows researchers to evaluate inflammatory responses, tissue compatibility, and the presence of adverse reactions such as fibrosis or necrosis.⁴⁷

CHALLENGES AND LIMITATIONS:

Stability Issues of Smart Polymer Matrices:

Stability issues for smart polymer matrices could include physical instability, deterioration, or functional loss over time.

Biocompatibility Concerns and Tissue Response:

For smart polymer matrices used for biomedical applications, biocompatibility is an essential factor to take into account. Despite the fact that a large number of polymers utilized in drug delivery systems are biocompatible, some polymer degradation products or leftover monomers may cause cytotoxicity, immunogenicity, or inflammatory reactions.⁴⁸

Scalability and Manufacturing Challenges:

The complexity of the polymer synthesis, formulation, and processing techniques impedes the creation of smart polymer matrices and their scalability. Regulatory compliance, quality control procedure validation, and manufacturing parameter optimization may be necessary for the clinical translation production processes to scale up.

FUTURE PERSPECTIVES AND OPPORTUNITIES:

Emerging Technologies and Innovative Approaches:

The merger of cutting-edge technologies and creative thinking to improve treatment outcomes is where smart polymer-based drug delivery systems will find their future. Advanced imaging technologies that offer precise spatiotemporal control over drug distribution, such real-time monitoring and feedback systems, can be incorporated to facilitate individualized treatment regimens.⁴⁹

Potential for Personalized Medicine in Angina Treatment:

By customizing medication to each patient's unique traits, disease profile, and response to treatment, smart polymer-based drug delivery devices hold the promise to enable personalized medicine methods in the treatment of angina. Furthermore, patient-centric strategies, such wearable technology and patient-controlled medication delivery systems, enable people to take an active role in controlling their angina symptoms and tracking the effectiveness of their treatment in real time.⁵⁰

Integration with Other Drug Delivery Platforms:

Combined with various drug delivery platforms, smart polymer-based drug delivery systems provide synergistic benefits for improved clinical utility and therapeutic efficacy. Integration with digital health technologies, like mobile health applications and telemedicine platforms, also makes it easier for angina patients to receive tailored dose schedules, remote monitoring, and data-driven treatment strategy optimization.⁵¹

CONCLUSION:

Finally, intelligent polymer matrices present a viable method for drug release on-demand, particularly for ailments like angina. Preclinical research demonstrates their effectiveness in delivering drugs with minimal systemic side effects and a focused approach. In order to improve therapy outcomes and enable personalized medicine methods, future research prospects involve incorporating emerging technologies such as digital health platforms and nanotechnology. It may be possible to address unmet therapeutic requirements in cardiovascular diseases by investigating novel stimuli-responsive polymers, innovative formulations, and combination medicines. The optimization of smart polymer-based drug delivery will be facilitated by interdisciplinary cooperation and technical advancements, leading to an improvement in treatment efficacy and patient outcomes.

REFERENCES:

1. Abdelkader H, Fathalla Z, Seyfoddin A, Farahani M, Thrimawithana T, Allahham A, Alani AW, Al-Kinani AA, Alany RG. Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants. Advanced Drug Delivery Reviews. 2021; Oct 1; 177: 113957.

2. Azman M, Sabri AH, Anjani QK, Mustaffa MF, Hamid KA. Intestinal absorption study: Challenges and absorption enhancement strategies in improving oral drug delivery. Pharmaceuticals. 2022 Aug 8;15(8):975.

3. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Frontiers in Pharmacology. 2021; Feb 19; 12: 618411.

4. Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nature Reviews Drug Discovery. 2023; May; 22(5): 387-409.

5. St Clair-Jones A, Prignano F, Goncalves J, Paul M, Sewerin P. Understanding and minimising injection-site pain following subcutaneous administration of biologics: a narrative review. Rheumatology and Therapy. 2020; Dec; 7: 741-57.

6. Dubashynskaya NV, Skorik YA. Patches as polymeric systems for improved delivery of topical corticosteroids: Advances and future perspectives. International Journal of Molecular Sciences. 2022 Oct 26;23(21):12980.

7. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021 Sep 29;26(19):5905.

8. Khan SB, Chen S, Sun X. Advancements in polymer nanocomposite manufacturing: revolutionizing medical breakthroughs via additive manufacturing. Polymer Bulletin. 2024 Feb 18:1-53.

9. Laffleur F, Keckeis V. Advances in drug delivery systems: Work in progress still needed?. International Journal of Pharmaceutics. 2020 Nov 30;590:119912.

10. Tyson RJ, Park CC, Powell JR, Patterson JH, Weiner D, Watkins PB, Gonzalez D. Precision dosing priority criteria: drug, disease, and patient population variables. Frontiers in Pharmacology. 2020 Apr 22;11:420.

11. El-Ghoul Y, Alminderej FM, Alsubaie FM, Alrasheed R, Almousa NH. Recent advances in functional polymer materials for energy, water, and biomedical applications: a review. Polymers. 2021 Dec 10; 13(24): 4327.

12. Korde JM, Kandasubramanian B. Naturally biomimicked smart shape memory hydrogels for biomedical functions. Chemical Engineering Journal. 2020 Jan 1; 379: 122430.

13. Hou Z, Xia S, Niu C, Pang Y, Sun H, Li Z, Xu Y, Zheng S. Tailoring the interaction of covalent organic framework with the polyether matrix toward high‐performance solid‐state lithium metal batteries. Carbon Energy. 2022 Jul; 4(4): 506-16.

14. Dabbaghi A, Ramazani A, Farshchi N, Rezaei A, Bodaghi A, Rezayati S. Synthesis, physical and mechanical properties of amphiphilic hydrogels based on polycaprolactone and polyethylene glycol for bioapplications: A review. Journal of Industrial and Engineering Chemistry. 2021 Sep 25;101:307-23.

15. Venkatachalam D, Pushparaju S. Smart Polymer Hydrogels as Matrices for the Controlled Release Applications in Agriculture Sector. InHydrogels-From Tradition to Innovative Platforms with Multiple Applications 2022 Apr 18. IntechOpen.

16. Yang P, Zhu F, Zhang Z, Cheng Y, Wang Z, Li Y. Stimuli-responsive polydopamine-based smart materials. Chemical Society Reviews. 2021; 50(14): 8319-43.

17. Municoy S, Alvarez Echazu MI, Antezana PE, Galdopórpora JM, Olivetti C, Mebert AM, Foglia ML, Tuttolomondo MV, Alvarez GS, Hardy JG, Desimone MF. Stimuli-responsive materials for tissue engineering and drug delivery. International Journal of Molecular Sciences. 2020 Jul 2; 21(13): 4724.

18. Chauhan R, Kushwah P, Mourya H, Garud N, Joshi R, Akram W, Kumar P, Haider T. Nanocarriers for Topical Delivery of Drug. InSmart Nanocarrier for Effective Drug Delivery (pp. 224-242). CRC Press.

19. Yuan Z, Ding J, Zhang Y, Huang B, Song Z, Meng X, Ma X, Gong X, Huang Z, Ma S, Xiang S. Components, mechanisms and applications of stimuli-responsive polymer gels. European Polymer Journal. 2022 Aug 15; 177: 111473.

20. Ofridam F, Tarhini M, Lebaz N, Gagnière É, Mangin D, Elaissari A. pH‐sensitive polymers: Classification and some fine potential applications. Polymers for Advanced Technologies. 2021 Apr; 32(4): 1455-84.

21. Gonzalez-Obeso C, Rodriguez-Cabello JC, Kaplan DL. Fast and reversible crosslinking of a silk elastin-like polymer. Acta Biomaterialia. 2022; Mar 15; 141: 14-23.

22. Ofridam F, Tarhini M, Lebaz N, Gagnière É, Mangin D, Elaissari A. pH‐sensitive polymers: Classification and some fine potential applications. Polymers for Advanced Technologies. 2021 Apr; 32(4): 1455-84.

23. Tan RY, Lee CS, Pichika MR, Cheng SF, Lam KY. PH responsive polyurethane for the advancement of biomedical and drug delivery. Polymers. 2022; Apr 20; 14(9): 1672.

24. Chauhan R. A design of experiment-based approach for the formulation development and evaluation of repaglinide transdermal patch using natural polymers. Asian Journal of Pharmaceutics (AJP). 2022; Jun 15; 16(2).

25. Badreldin M, Ambrosio PS, Garanger E, Lecommandoux S, Harrisson S, Bonduelle C. Thermoresponsive polymers: from natural proteins to amino acid based polymer synthesis. Progress in Polymer Science. 2023; Oct 22: 101752.

26. Lerch A, Käfer F, Prévost S, Agarwal S, Karg M. Structural Insights into Polymethacrylamide-Based LCST Polymers in Solution: A Small-Angle Neutron Scattering Study. Macromolecules. 2021; Aug 5; 54(16): 7632-41.

27. Wang J, Liu L, Zhang S, Liao B, Zhao K, Li Y, Xu J, Chen L. Review of the Perspectives and Study of Thermo-Responsive Polymer Gels and Applications in Oil-Based Drilling Fluids. Gels. 2023; Dec 11; 9(12): 969.

28. Van Guyse JF, Bera D, Hoogenboom R. Adamantane Functionalized Poly (2-oxazoline) s with Broadly Tunable LCST-Behavior by Molecular Recognition. Polymers. 2021; Jan 26; 13(3): 374.

29. Nastyshyn S, Stetsyshyn Y, Raczkowska J, Nastishin Y, Melnyk Y, Panchenko Y, Budkowski A. Temperature-responsive polymer brush coatings for advanced biomedical applications. Polymers. 2022; Oct 10; 14(19): 4245.

30. Zhang Q, Zhang Y, Wan Y, Carvalho W, Hu L, Serpe MJ. Stimuli-responsive polymers for sensing and reacting to environmental conditions. Progress in Polymer Science. 2021; May 1; 116: 101386.

31. Rajendra C, Naveen M, Anurekha J, Sanjay J, Kumar JA, Gupta MK. Optimization of plasticizer for diclofenac sodium transdermal film: Permeation enhancement. Asian J Pharm Clin Res. 2011; 4:1178-80.

32. Panja S, Adams DJ. Stimuli responsive dynamic transformations in supramolecular gels. Chemical Society Reviews. 2021; 50(8): 5165-200.

33. Pan P, Svirskis D, Rees SW, Barker D, Waterhouse GI, Wu Z. Photosensitive drug delivery systems for cancer therapy: Mechanisms and applications. Journal of Controlled Release. 2021; Oct 10; 338: 446-61.

34. Jamaledin R, Makvandi P, Yiu CK, Agarwal T, Vecchione R, Sun W, Maiti TK, Tay FR, Netti PA. Engineered microneedle patches for controlled release of active compounds: recent advances in release profile tuning. Advanced Therapeutics. 2020; Dec; 3(12): 2000171.

35. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021; Sep 29; 26(19): 5905.

36. Zhao Z, Ukidve A, Kim J, Mitragotri S. Targeting strategies for tissue-specific drug delivery. Cell. 2020; Apr 2; 181(1): 151-67.

37. Municoy S, Alvarez Echazu MI, Antezana PE, Galdopórpora JM, Olivetti C, Mebert AM, Foglia ML, Tuttolomondo MV, Alvarez GS, Hardy JG, Desimone MF. Stimuli-responsive materials for tissue engineering and drug delivery. International Journal of Molecular Sciences. 2020; Jul 2; 21(13): 4724.

38. Finbloom JA, Sousa F, Stevens MM, Desai TA. Engineering the drug carrier biointerface to overcome biological barriers to drug delivery. Advanced Drug Delivery Reviews. 2020; Dec 1; 167: 89-108.

39. Kumar K, Umapathi R, Ramesh K, Hwang SK, Lim KT, Huh YS, Venkatesu P. Biological stimuli-induced phase transition of a synthesized block copolymer: preferential interactions between PNIPAM-b-PNVCL and heme proteins. Langmuir. 2021; Jan 25; 37(5): 1682-96.

40. Schoeller J, Itel F, Wuertz-Kozak K, Fortunato G, Rossi RM. pH-responsive electrospun nanofibers and their applications. Polymer Reviews. 2022; Apr 27; 62(2): 351-99.

41. Shi D, Beasock D, Fessler A, Szebeni J, Ljubimova JY, Afonin KA, Dobrovolskaia MA. To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives. Advanced Drug Delivery Reviews. 2022; Jan 1; 180: 114079.

42. The Effect of Natural Polymers On Transdermal Drug Delivery System RJ Rajendra Chauhan1, Navneet Garud1, Hemant Mourya, Trapti Sahu, Preeti Sharma Bulletin of Environment, Pharmacology and Life Sciences. 12 (7), 299- 303

43. Su Y, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, Wang R, Chen C. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Delivery. 2021; Jan 1; 28(1): 1397-418.

44. Joshi R, Akram W, Chauhan R, Garud N. Thin films: a promising approach for drug delivery system. Drug Carriers. 2022; Mar 27. IntechOpen.

45. Mourya H, Chauhan R, Joshi R, Akram W, Garud N. Bilayer tablets: a promising novel drug delivery system. Research Journal of Pharmacy and Technology. 2023; 16(5): 2517-21.

46. Shi M, McHugh KJ. Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems. Advanced Drug Delivery Reviews. 2023; May 30: 114904.

47. Mirabedini A, Ang A, Nikzad M, Fox B, Lau KT, Hameed N. Evolving strategies for producing multiscale graphene‐enhanced fiber‐reinforced polymer composites for smart structural applications. Advanced Science. 2020; Jun; 7(11): 1903501.

48. Khan MI, Hossain MI, Hossain MK, Rubel MH, Hossain KM, Mahfuz AM, Anik MI. Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review. ACS Applied Bio Materials. 2022; Feb 28; 5(3): 971-1012.

49. Patel DH, editor. Bioresponsive Polymers: Design and Application in Drug Delivery. CRC Press; 2020 Oct 8.

50. Yu M, Cao R, Ma Z, Zhu M. Development of “smart” drug delivery systems for chemo/PDT synergistic treatment. Journal of Materials Chemistry B. 2023; 11(7): 1416-33.

51. Ford TJ, Berry C. Angina: contemporary diagnosis and management. Heart. 2020; Mar 1; 106(5): 387-98.

Received on 28.06.2024 Revised on 30.09.2024

Accepted on 14.11.2024 Published on 12.06.2025

Available online from June 14, 2025

Research J. Pharmacy and Technology. 2025;18(6):2903-2909.

DOI: 10.52711/0974-360X.2025.00417

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

Smart Polymer Matrix	Stimulus	Properties	Applications
pH-Responsive Polymers	pH	· Ionizable groups undergo protonation/deprotonation · Swelling behavior controlled by pH changes	· Oral drug delivery · Colon-specific drug release · Tumor targeting
Temperature-Responsive	Temperature	· LCST or UCST behavior	· On-demand drug release · Thermally-triggered drug delivery
Light-Responsive Polymers	Light intensity	· Photoisomerization or photodimerization · Reversible changes in polymer conformation	· Controlled drug release based on light exposure · Photodynamic therapy
Enzyme-Responsive Polymers	Enzyme activity	· Cleavage of specific peptide sequences · Selective release in the presence of target enzymes	· Targeted drug delivery · Enzyme-triggered drug release
Magnetic-Responsive Polymers	Magnetic field	· Response to external magnetic fields · Manipulation or actuation through magnetic fields	· Targeted drug delivery · Magnetic resonance imaging contrast agents
Electric-Responsive Polymers	Electric field	· Electroactive behaviour · Changes in mechanical, optical, or electrical properties	· Electroactive drug delivery systems · Biosensors